(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne

C220H133F10N15O18S5 — CID 159914252

IUPAC(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne
SMILESC.C#CC#CC#CC#CC#CC#CC#CC#CC#CC.C#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC.C#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#C.CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC.CC(C=O)NC(=O)[C@H]1C[C@H]2CSC(NC(=O)c3ccccc3)=N[C@@]2(c2ccc(F)cc2F)CO1.CC(CO)NC(=O)[C@H]1C[C@H]2CSC(NC(=O)c3ccccc3)=N[C@@]2(c2ccc(F)cc2F)CO1.CC(N)CO.Cc1coc([C@H]2C[C@H]3CSC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)n1.Cc1coc([C@H]2C[C@H]3CSC(NC(=O)c4ccccc4)=N[C@@]3(c3ccc(F)cc3F)CO2)n1.O=C(NC1=N[C@@]2(c3ccc(F)cc3F)CO[C@@H](C(=O)O)C[C@H]2CS1)c1ccccc1
InChIInChI=1S/C30H2.C29H4.C28H6.C24H25F2N3O4S.C24H23F2N3O4S.C24H21F2N3O3S.C21H18F2N2O4S.C19H4.C17H17F2N3O2S.C3H9NO.CH4/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-28-26-24-22-20-18-16-14-12-10-8-6-4-2;1-3-5-7-9-11-13-15-17-19-21-23-25-27-28-26-24-22-20-18-16-14-12-10-8-6-4-2;2*1-14(11-30)27-22(32)20-9-16-12-34-23(28-21(31)15-5-3-2-4-6-15)29-24(16,13-33-20)18-8-7-17(25)10-19(18)26;1-14-11-31-22(27-14)20-9-16-12-33-23(28-21(30)15-5-3-2-4-6-15)29-24(16,13-32-20)18-8-7-17(25)10-19(18)26;22-14-6-7-15(16(23)9-14)21-11-29-17(19(27)28)8-13(21)10-30-20(25-21)24-18(26)12-4-2-1-3-5-12;1-3-5-7-9-11-13-15-17-19-18-16-14-12-10-8-6-4-2;1-9-6-23-15(21-9)14-4-10-7-25-16(20)22-17(10,8-24-14)12-3-2-11(18)5-13(12)19;1-3(4)2-5;/h1-2H;1H,2H3;1-2H3;2-8,10,14,16,20,30H,9,11-13H2,1H3,(H,27,32)(H,28,29,31);2-8,10-11,14,16,20H,9,12-13H2,1H3,(H,27,32)(H,28,29,31);2-8,10-11,16,20H,9,12-13H2,1H3,(H,28,29,30);1-7,9,13,17H,8,10-11H2,(H,27,28)(H,24,25,26);1H,2H3;2-3,5-6,10,14H,4,7-8H2,1H3,(H2,20,22);3,5H,2,4H2,1H3;1H4/t;;;2*14?,16-,20+,24-;16-,20+,24-;13-,17+,21-;;10-,14+,17-;;/m...0000.0../s1
InChIKeyNXOPARCWPOASRH-JWCAUHLFSA-N
MW3624.89 g/mol
LogP19.32
Rot. Bonds19

About (4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne

(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne (PubChem CID 159914252) has the molecular formula C220H133F10N15O18S5 and a molecular weight of 3624.89 g/mol. Its IUPAC name is (4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne.

Molecular Properties

Compound Name(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne
PubChem CID159914252
Molecular FormulaC220H133F10N15O18S5
Molecular Weight3624.89 g/mol
Exact Mass3621.84
IUPAC Name(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne
SMILESC.C#CC#CC#CC#CC#CC#CC#CC#CC#CC.C#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC.C#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#C.CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC.CC(C=O)NC(=O)[C@H]1C[C@H]2CSC(NC(=O)c3ccccc3)=N[C@@]2(c2ccc(F)cc2F)CO1.CC(CO)NC(=O)[C@H]1C[C@H]2CSC(NC(=O)c3ccccc3)=N[C@@]2(c2ccc(F)cc2F)CO1.CC(N)CO.Cc1coc([C@H]2C[C@H]3CSC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)n1.Cc1coc([C@H]2C[C@H]3CSC(NC(=O)c4ccccc4)=N[C@@]3(c3ccc(F)cc3F)CO2)n1.O=C(NC1=N[C@@]2(c3ccc(F)cc3F)CO[C@@H](C(=O)O)C[C@H]2CS1)c1ccccc1
InChIInChI=1S/C30H2.C29H4.C28H6.C24H25F2N3O4S.C24H23F2N3O4S.C24H21F2N3O3S.C21H18F2N2O4S.C19H4.C17H17F2N3O2S.C3H9NO.CH4/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-28-26-24-22-20-18-16-14-12-10-8-6-4-2;1-3-5-7-9-11-13-15-17-19-21-23-25-27-28-26-24-22-20-18-16-14-12-10-8-6-4-2;2*1-14(11-30)27-22(32)20-9-16-12-34-23(28-21(31)15-5-3-2-4-6-15)29-24(16,13-33-20)18-8-7-17(25)10-19(18)26;1-14-11-31-22(27-14)20-9-16-12-33-23(28-21(30)15-5-3-2-4-6-15)29-24(16,13-32-20)18-8-7-17(25)10-19(18)26;22-14-6-7-15(16(23)9-14)21-11-29-17(19(27)28)8-13(21)10-30-20(25-21)24-18(26)12-4-2-1-3-5-12;1-3-5-7-9-11-13-15-17-19-18-16-14-12-10-8-6-4-2;1-9-6-23-15(21-9)14-4-10-7-25-16(20)22-17(10,8-24-14)12-3-2-11(18)5-13(12)19;1-3(4)2-5;/h1-2H;1H,2H3;1-2H3;2-8,10,14,16,20,30H,9,11-13H2,1H3,(H,27,32)(H,28,29,31);2-8,10-11,14,16,20H,9,12-13H2,1H3,(H,27,32)(H,28,29,31);2-8,10-11,16,20H,9,12-13H2,1H3,(H,28,29,30);1-7,9,13,17H,8,10-11H2,(H,27,28)(H,24,25,26);1H,2H3;2-3,5-6,10,14H,4,7-8H2,1H3,(H2,20,22);3,5H,2,4H2,1H3;1H4/t;;;2*14?,16-,20+,24-;16-,20+,24-;13-,17+,21-;;10-,14+,17-;;/m...0000.0../s1
InChIKeyNXOPARCWPOASRH-JWCAUHLFSA-N
XLogP19.32
TPSA481.48 Ų
H-Bond Donors11
H-Bond Acceptors31
Rotatable Bonds19
Heavy Atoms268
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003624.89
LogP ≤ 519.32
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze (4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne?
The IUPAC name of (4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne (CID 159914252) is (4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne.
What is the SMILES notation for (4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne?
The canonical SMILES for (4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne is C.C#CC#CC#CC#CC#CC#CC#CC#CC#CC.C#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC.C#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#C.CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC#CC.CC(C=O)NC(=O)[C@H]1C[C@H]2CSC(NC(=O)c3ccccc3)=N[C@@]2(c2ccc(F)cc2F)CO1.CC(CO)NC(=O)[C@H]1C[C@H]2CSC(NC(=O)c3ccccc3)=N[C@@]2(c2ccc(F)cc2F)CO1.CC(N)CO.Cc1coc([C@H]2C[C@H]3CSC(N)=N[C@@]3(c3ccc(F)cc3F)CO2)n1.Cc1coc([C@H]2C[C@H]3CSC(NC(=O)c4ccccc4)=N[C@@]3(c3ccc(F)cc3F)CO2)n1.O=C(NC1=N[C@@]2(c3ccc(F)cc3F)CO[C@@H](C(=O)O)C[C@H]2CS1)c1ccccc1.
What is the InChIKey of (4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne?
The InChIKey is NXOPARCWPOASRH-JWCAUHLFSA-N. The full InChI is InChI=1S/C30H2.C29H4.C28H6.C24H25F2N3O4S.C24H23F2N3O4S.C24H21F2N3O3S.C21H18F2N2O4S.C19H4.C17H17F2N3O2S.C3H9NO.CH4/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-28-26-24-22-20-18-16-14-12-10-8-6-4-2;1-3-5-7-9-11-13-15-17-19-21-23-25-27-28-26-24-22-20-18-16-14-12-10-8-6-4-2;2*1-14(11-30)27-22(32)20-9-16-12-34-23(28-21(31)15-5-3-2-4-6-15)29-24(16,13-33-20)18-8-7-17(25)10-19(18)26;1-14-11-31-22(27-14)20-9-16-12-33-23(28-21(30)15-5-3-2-4-6-15)29-24(16,13-32-20)18-8-7-17(25)10-19(18)26;22-14-6-7-15(16(23)9-14)21-11-29-17(19(27)28)8-13(21)10-30-20(25-21)24-18(26)12-4-2-1-3-5-12;1-3-5-7-9-11-13-15-17-19-18-16-14-12-10-8-6-4-2;1-9-6-23-15(21-9)14-4-10-7-25-16(20)22-17(10,8-24-14)12-3-2-11(18)5-13(12)19;1-3(4)2-5;/h1-2H;1H,2H3;1-2H3;2-8,10,14,16,20,30H,9,11-13H2,1H3,(H,27,32)(H,28,29,31);2-8,10-11,14,16,20H,9,12-13H2,1H3,(H,27,32)(H,28,29,31);2-8,10-11,16,20H,9,12-13H2,1H3,(H,28,29,30);1-7,9,13,17H,8,10-11H2,(H,27,28)(H,24,25,26);1H,2H3;2-3,5-6,10,14H,4,7-8H2,1H3,(H2,20,22);3,5H,2,4H2,1H3;1H4/t;;;2*14?,16-,20+,24-;16-,20+,24-;13-,17+,21-;;10-,14+,17-;;/m...0000.0../s1.
What are the key properties of (4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne?
(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne has a molecular weight of 3624.89 g/mol, XLogP of 19.32, 19 rotatable bonds, 11 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for (4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-amine;N-[(4aR,6R,8aS)-8a-(2,4-difluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-2-yl]benzamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxylic acid;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-hydroxypropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;(4aR,6R,8aS)-2-benzamido-8a-(2,4-difluorophenyl)-N-(1-oxopropan-2-yl)-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazine-6-carboxamide;2-aminopropan-1-ol;methane;nonacosa-1,3,5,7,9,11,13,15,17,19,21,23,25,27-tetradecayne;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-tridecayne;triaconta-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29-pentadecayne is sourced from PubChem (CID 159914252), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).